Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hib Vaccine Injection Site Safety and Immunogenicity
NCT01761136Phase 4Completed
- Sponsor
- Beijing Center for Disease Control and Prevention
- Start
- Nov 2011
- Primary completion
- Dec 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of haemophilus influenzae type b vaccine in Haemophilus influenzae type b infection (Hib), sponsored by Beijing Center for Disease Control and Prevention. Started Nov 2011; status: completed.
02
Drugs
haemophilus influenzae type b vaccine
03
Conditions
Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01761136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01761136.